Daniel R Kaul

 Daniel R. Kaul
Clinical Professor
Email:
[email protected]
Available to mentor
Daniel R Kaul
Daniel R. Kaul
Clinical Professor
  • Recent Publications

  • Manage Your Profile

    • Recent Publications

     See All Publications
    • Journal Article
      Transparency and Continuity in Organ Safety and Vigilance: Concerns Regarding the Transition from DTAC to TRACE
      Ison MG, Blumberg E, Green M, Kaul D, Wolfe CR, Michaels MG, La Hoz RM, Danziger-Isakov L. American Journal of Transplantation, 2026 Oct 17; DOI:10.1016/j.ajt.2026.10.011
    • Journal Article
      Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment
      Raglow Z, Kaul D, Rodriguez AM, Oliveira Gonçalves AS, Henry-Szatkowski M, Ginchereau Sowell F, Bullano M, Gelone DK, Schultz BG. Current Medical Research and Opinion, 2026 May 28; 1 - 11. DOI:10.1080/03007995.2026.2676335
    • Preprint
      Second multistate outbreak of tuberculosis caused by a bone allograft product
      Schildknecht KR, Williams PM, Schwartz NG, Haddad MB, Stewart RJ, Annambhotla P, Basavaraju SV, Nabity SA, Keh CE, Calvet HM, Zahn MM, Beltran R, Cortez A, Lomeli A, Percak JM, Gooze LL, Coloma M, Shaw T, Davidson PJ, Smith SR, Dickson RP, Kaul DR, Gonzalez AR, Rodriguez G, Decimo A, Sanchez A, Armitige LY, Stapleton J, Lacassagne M, Brown C, Zheng C, Ali J, Wolfe AW, Young LR, Ariail K, Behm H, Jordan HT, Spencer M, Nilsen DM, Goradia R, Montoya Denison B, Burgos M, Leonard JM, Cortes E, Thacker TC, Lehman KA, Villalba JA, Bhatnagar J, Reagan-Steiner S, Althomsons SP, Goswami ND, Cowan LS, Starks AM, Wortham JM, LoBue PA. 2026 May 8; medRxiv, DOI:10.64898/2026.04.29.26351868
    • Journal Article
      A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
      Boutin C-A, Callegari M, Florescu D, Nguyen MH, Kaul D, Avery R, Chong P, Fisher C, Limaye AP, Clough L, Pergam SA, Green M, Michaels MG, Danziger-Isakov L, Angarone M, Keefer L, Daud A, Lorenzo-Redondo R, Tan M, Ison MG. American Journal of Transplantation, 2026 May 22; DOI:10.1016/j.ajt.2026.04.010
    • Proceeding / Abstract / Poster
      (1474) Incidence of Herpes Zoster Virus Infection in Lung Transplant Recipients on Long-Term HZV Prophylaxis
      Zimmerman MS, Hixson H, Walter K, Chan K, Kaul D, Combs M. The Journal of Heart and Lung Transplantation, 2026 May 6; 45 (5): 679 - 679. DOI:10.1016/j.healun.2026.02.1488
    • Journal Article
      IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients.
      Nellore A, Goepfert P, Tan CS, Bajema K, Belden K, Blumberg D, Katz MJ, Kaul D, Sharma T, Anjan S, Ariza-Heredia EJ, Magana F, Minniear T, Loveless J, Kaur D, York E, Falck-Ytter Y, Baden L. Clin Infect Dis, 2026 Mar 2; DOI:10.1093/cid/ciag114
      PMID: 41766454
    • Journal Article
      IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients.
      Goepfert P, Katz MJ, Kaul D, Sharma T, Kaur D, Falck-Ytter Y, Baden L. Clin Infect Dis, 2026 Feb 28; DOI:10.1093/cid/ciag116
      PMID: 41762115
    • Journal Article
      Healthcare Provider (HCP) Preferences for Treatment of Post-Transplant Cytomegalovirus Infection (CMVi)
      Taber D, Raglow Z, Kaul D, Rodriguez A, Henry-Szatkowski M, Sowell FG, Bullano M, Schultz BG, Gelone DK. American Journal of Transplantation, 2025 Aug 4; 25 (8): s589 DOI:10.1016/j.ajt.2025.07.1377